CT55 and plasma cell myeloma: These CTLs were able to recognize myeloma cells, such as KMS21 and KMM1, with high levels of CXorf48 expression, but not those with low levels of antigen expression, suggesting that this antigen could be a therapeutic target, at least in myeloma patients expressing high levels of CXorf48.